Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126866741 | 12686674 | 1 | I | 20160127 | 20160825 | 20160825 | EXP | CA-ELI_LILLY_AND_COMPANY-CA201601010254 | ELI LILLY AND CO | 0.00 | F | Y | 0.00000 | 20160824 | OT | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126866741 | 12686674 | 1 | PS | CYMBALTA | DULOXETINE HYDROCHLORIDE | 1 | Unknown | UNK, UNKNOWN | U | U | 21427 | CAPSULE | |||||||
| 126866741 | 12686674 | 2 | SS | HYDROMORPH CONTIN | HYDROMORPHONE | 1 | Unknown | UNK, UNKNOWN | U | 0 | |||||||||
| 126866741 | 12686674 | 3 | SS | HYDROMORPHONE | HYDROMORPHONE | 1 | Unknown | UNK, UNKNOWN | U | 0 | |||||||||
| 126866741 | 12686674 | 4 | SS | XELJANZ | TOFACITINIB CITRATE | 1 | Oral | UNK, UNKNOWN | U | 0 | 5 | MG | BID | ||||||
| 126866741 | 12686674 | 5 | SS | LYRICA | PREGABALIN | 1 | Oral | UNK, UNKNOWN | U | 0 | |||||||||
| 126866741 | 12686674 | 6 | C | METHOTREXATE. | METHOTREXATE | 1 | Unknown | UNK, UNKNOWN | U | 0 | 20 | MG | /wk | ||||||
| 126866741 | 12686674 | 7 | C | ENBREL | ETANERCEPT | 1 | Subcutaneous | 50 MG, WEEKLY (1/W) | U | 0 | 50 | MG | /wk | ||||||
| 126866741 | 12686674 | 8 | C | SULFASALAZINE. | SULFASALAZINE | 1 | Oral | 1 G, BID | U | 0 | 1 | G | BID | ||||||
| 126866741 | 12686674 | 9 | C | HYDROXYCHLOROQUINE | HYDROXYCHLOROQUINE | 1 | Unknown | 400 MG, QD | U | 0 | 400 | MG | QD | ||||||
| 126866741 | 12686674 | 10 | C | LEFLUNOMIDE. | LEFLUNOMIDE | 1 | Unknown | 20 MG, QD | U | 0 | 20 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126866741 | 12686674 | 1 | Product used for unknown indication |
| 126866741 | 12686674 | 2 | Product used for unknown indication |
| 126866741 | 12686674 | 3 | Product used for unknown indication |
| 126866741 | 12686674 | 4 | Rheumatoid arthritis |
| 126866741 | 12686674 | 5 | Product used for unknown indication |
| 126866741 | 12686674 | 6 | Rheumatoid arthritis |
| 126866741 | 12686674 | 7 | Rheumatoid arthritis |
| 126866741 | 12686674 | 8 | Rheumatoid arthritis |
| 126866741 | 12686674 | 9 | Product used for unknown indication |
| 126866741 | 12686674 | 10 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126866741 | 12686674 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126866741 | 12686674 | Costochondritis | |
| 126866741 | 12686674 | Fatigue | |
| 126866741 | 12686674 | Inflammation | |
| 126866741 | 12686674 | Pain | |
| 126866741 | 12686674 | Rheumatoid arthritis | |
| 126866741 | 12686674 | Somnolence | |
| 126866741 | 12686674 | Swelling |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126866741 | 12686674 | 4 | 20150401 | 0 | ||
| 126866741 | 12686674 | 6 | 200709 | 200803 | 0 | |
| 126866741 | 12686674 | 7 | 2010 | 0 | ||
| 126866741 | 12686674 | 8 | 200709 | 200803 | 0 | |
| 126866741 | 12686674 | 9 | 200709 | 200803 | 0 | |
| 126866741 | 12686674 | 10 | 200901 | 200912 | 0 |